Daily as of 3 Nov 16:00 ET
- Price
- below both $13.02 vs 50 $24.13 / 200 $26.87
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 19 Oct 2026 · projected 9 bars out
AVBP | ArriVent BioPharmaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$13.02
-$0.33 (-2.47%)
ArriVent BioPharma (AVBP) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- below both $13.35 vs 50 $18.80 / 200 $27.91
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 19 Oct 2026 | 💀Death steep | daily | 9 bars out | Not tested |
| 10 Dec 2025 | 🟨Golden moderate | daily | 7 bars out | 1 bar cross test |
| 24 Mar 2025 | 💀Death steep | daily | 30 bars out | Not tested |
About AVBP
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$15.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandsmall